Presentations and outcomes of interstitial lung disease and the anti-Ro52 autoantibody

BACKGROUND: Distinct clinical presentations of interstitial lung disease (ILD) with the myositis-specific antibodies, including anti-synthetase antibodies, are well-recognized. However, the association between ILD and the myositis-associated antibodies, including anti-Ro52, is less established. Our...

Descripción completa

Detalles Bibliográficos
Autores principales: Sclafani, A., D’Silva, K. M., Little, B. P., Miloslavsky, E. M., Locascio, J. J., Sharma, A., Montesi, S. B.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2019
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6852961/
https://www.ncbi.nlm.nih.gov/pubmed/31718649
http://dx.doi.org/10.1186/s12931-019-1231-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6852961/
https://www.ncbi.nlm.nih.gov/pubmed/31718649
http://dx.doi.org/10.1186/s12931-019-1231-7

Ejemplares similares